compared to total revenue from medical treatment for the fiscal year 2018 and 2019, equaled to 70.5% and 81.4% respectively. The major proportion in cost of medical treatments were derived from cost incurred
of Company and its subsidiary amounted Baht 539.4 million. The main liabilities were current liabilities totaled Baht 324.8 million or 60.2 percent of total liabilities while non-current liabilities
of Company and its subsidiary amounted Baht 539.4 million. The main liabilities were current liabilities totaled Baht 324.8 million or 60.2 percent of total liabilities while non-current liabilities
Protection Act. Discussion and Analysis of the Company and its subsidiaries Operational Results in Q2/2019 and Q2/2018 Corporate Revenue In Q2/2019 the Company and its subsidiaries’ total earnings amounted to
them as total liabilities in the calculation of net capital on the condition that they rectify the excess qualified subordinated debt so as not to surpass the shareholders’ equity within a specified
companies in 2017 was 9,612.85 million THB, decreasing 4,988.67 million THB or 34.17% from that in 2016. More than 90% of the main income was achieved from sale which decreased from 13,855.41 million THB in
liabilities The total liabilities increased 1,178.93 million THB or 13.72% i.e. from 8,592.92 million THB to 9,771.85 million THB. The main reasons are as follows: 1. The Company borrowed from financial
and explanation For the three-month period ended 31 March 2020, the Company’s sales increased by Baht 149.9 million or 13.6% compared to the same period of 2019. The main reason was that CPO price
443.59 97.50 (209.94) (47.33) Other income 4.28 1.80 4.53 1.01 53.80 31.19 11.39 2.50 (0.25) (5.52) Total income 237.93 100.00 448.12 100.00 172.51 100.00 454.98 100.00 (210.19) (46.90) Cost of real estate
electricity sales volume by 16 Gigawatt-Hours or 3% due to maintenance shutdown of main customers in Q1/2018. Q2/2018 VS Q2/2017 (YoY) • Total revenue for Q2/2018 increased by Baht 303 million or 9% when